Positive impactResults
Shilpa Medicare Q2 results: Net profit jumps 80%, revenue rises 43%
CNBC-TV18 36 min ago·5 Nov 2026, 9:10 am
Shilpa Medicare has reported a strong financial performance for the second quarter, with net profit rising by 80% year-on-year to ₹79 crore and revenue increasing by 43% to ₹529 crore. This growth reflects the company's ability to expand its market presence and operational scale.
For investors, the results indicate robust demand for the company's products, particularly in key international markets. The expansion of its peptide portfolio and the commencement of new supplies for European Contract Development and Manufacturing Organizations (CDMOs) suggest a positive outlook for future earnings.
Investors should monitor the execution of these expansion plans and the company's ability to sustain this growth momentum in the coming quarters.
Excerpt from CNBC-TV18
Published On Nov 5, 2026 | 14:40 IST Last Updated On Nov 5, 2026 | 14:40 IST Shilpa Medicare reported an 80% year-on-year jump in Q2 net profit to ₹79 crore, while revenue grew 43% to ₹529 crore. New customer wins in the US and Japan, peptide expansion and upcoming European CDMO supplies are expected to support FY27…Read the original at CNBC-TV18
Affected stocks
Bullish1 stock
Bull / bear label is derived from the article's AI sentiment — indicative, not advice. Prices may be delayed.
Key takeaways
- Concerns Shilpa Medicare (SHILPAMED).
- Category: Results.
- AI reads the tone as positive (potentially bullish) for the stock.
- Assessed as a significant, market-relevant update.
Why it matters
A meaningful update for Shilpa Medicare worth tracking. The tone is positive — historically associated with upward pressure, though not predictive. Use the price and stock snapshot to gauge how the market is responding.
